CroíValve Announces Funding from Horizon Europe EIC Accelerator
CroíValve, a pioneering medical device company innovating a better way to help more patients suffering from Tricuspid Regurgitation (TR), were awarded funding from Horizon Europe’s European Innovation Council (EIC) Accelerator Programme. Part of the EU’s Horizon...
Atlantic Technological University Signs Strategic Agreement with University of Illinois Chicago to Advance Urological Innovation
Atlantic Technological University (ATU) in Ireland and the University of Illinois Chicago (UIC) in the US have signed a Memorandum of Agreement (MoA) supporting a cross-institutional partnership focused on Urological Innovation, furthering bilateral collaboration in...
CroíValve Announces First Implant of a Novel Minimally Invasive Device for Tricuspid Regurgitation in US Early Feasibility Study
ATU iHub client company CroíValve, a pioneering medical device company focused on the development of a novel transcatheter device for the treatment of severe+ tricuspid regurgitation (TR), announced the first patient treated with the DUO™ System as part of the TANDEM...
